Tired of being on the wrong side of the trade? So was I until I joined LionStockAlerts . The alerts are quality, not junk and they are straight forward and cut out the hype.
Don't be such a nervous nellie. This is just big volume monkey games by all the big boys to maximize their trading profits pre-merger. What matters is that the merger closes. Then the stock will settle down and start to reflect the true value again.
Filed the paperwork to issue new SHPG shares to BXLT shareholders
Title of Each Class of Securities to be Registered: American Depositary Shares (“ADSs”), each ADS representing three (3) ordinary share s of Shire plc.
Amount to be Registered: 300,000,000 ADSs
Probably a bit of a stretch, but another factor could be the upcoming UK referendum on secession. US investment funds may be concerned of dive in the GBP and the implications that has on SHPG stock price. I still think this is mostly arbitragers trying to grab quick profits on the impending merger.
perhaps SGYP's news of having raised cash leaked a little early so down Shire went. That's what happens to fat cats when they get too greedy.
no reason, just getting shorted and today is a good day to do this.. baton down the hatches, great day to add to your position...
Sentiment: Strong Buy
Tired of being on the wrong side of the trade? So was I until I joined PennyStock101 The alerts are quality, not junk and they are straight forward and cut out the hype.
The report I quoted suggests that PFE could gain from an acquisition of SHPG even if new tax codes means there are no inversion benefits gained. Government can discourage companies from doing inversions by negating any tax benefits, but the only way to stop mergers if there is no tax benefit involved is through anti-trust provisions. Do you think PFE-SHPG would fail on anti-competition concerns?
Shpg in my opinion is a great example of tax inversion. It is really an American company. Pfe & agn aren't going to buy it because the government will not let them. Imho
Check out "TOP MARKET GAINERS dot com" (plug the address in your browser) it looks like they are about to have another big alert. Their last Nasdaq trade idea went up over 30%.
Analysts have been pointing to a buyout of SHPG by the likes of PFE, AGN, etc for several years. Now that are talking about how a takeover of SHPG makes sense, even if a buyout does not gain the benefit of tax inversion.
@Another stock to bounce this week was Shire, on 13.7 times prospective earnings, below a 10-year median of 16.7 times and as much as 25 in 2014. The stock has fallen more than 20 percent over the last year, as some investors worried over its costly deal to buy U.S. peer Baxalta. DEAL OR NO DEAL Exane BNP Paribas analyst David Finch added Shire to its M&A Target list, noting: "Big Pharma in general has other reasons than tax efficiency to make big acquisitions." He cites Shire's cheap valuation, as well as favourable forex conditions and the unsustainability of share buybacks, as contributing to the case for Pfizer to bid for Shire. And even if Shire resists an approach, the stock's valuation meant that: "Deal or no deal, we think we will make money."